Abstract:The Polo Like Kinases including the major family member, PLK1 are key regulatory enzymes controlling the cell cycle and mitosis. PLK1 is associated with poor survival rates in cancer and has been extensively investigated as an oncology drug target. Each member of the Polo like kinase family (PLKs 1-5) have two subdomains with independent functions and include the well conserved N-terminal kinase domain (KD) and the C-terminal polobox domain (PBD). The PBD is involved in the recognition of substrates primed by other kinases and in the PLK1 context is responsible for subcellular localization to specific sites in the nucleus including centrosomes and kinetochores. While the phosphosubstrate recognition site in PLKs 1-3 is highly conserved, its role in PLKs 2 and 3 is not well characterized and phosphopeptides that inhibit PLK1 have dramatically lower affinity for PLKs 2 and 3. An additional role of the PBD is its ability through domain-domain interactions with the KD to regulate PLK1 activity by an autoinhibited state of PLK1, conceptually similar to that which occurs through other kinases. Other mechanisms regulating PLK activity include the interchange between monomeric and dimeric forms, which inhibit or activate PLK1 during the cell cycle. Furthermore, PLK1 may exist as heterodimers with PLK2 and/or PLK3 and thus play context dependent roles. Here, through the use of the AlphaFold (AF) algorithm, structural insights into regulation of activity of the PLK1 and other family members have been obtained. These include dramatically different tertiary arrangement of the individual domains in each individual PLK. Analysis of the domain-domain interactions, interdomain and intradomain loops in each PLK sheds light onto plausible mechanisms by which the activity of each PLK is regulated and provides insights into the selectivity of phosphopeptides. The results also suggest a mechanism for the heterodimerization of PLK1 and PLK2 which has been observed in the literature.

Systematic analysis of the Plk-mediated phosphoregulation in eukaryotes.

Polo-like Kinase-1 Triggers Histone Phosphorylation by Haspin in Mitosis.

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1

Proteome-wide Prediction of PKA Phosphorylation Sites in Eukaryotic Kingdom.

Insights into the Structural Regulation of Polo-Like Kinase Activity using AlphaFold

Self-priming of Plk1 binding to BubR1 ensures accurate mitotic progression

Plk1-mediated Phosphorylation of UAP56 Regulates the Stability of UAP56

Polo-like kinase 1 is essential for early embryonic development and tumor suppression.

Integrative Structural Modeling of a Multidomain Polo-Like Kinase

Methylation of PLK1 by SET7/9 Ensures Accurate Kinetochore-Microtubule Dynamics.

Feedback Control of PLK1 by Apolo1 Ensures Accurate Chromosome Segregation

14-3-3Zeta Cooperates with Phosphorylated Plk1 and is Required for Correct Cytokinesis.

Plk1 inhibition delays mitotic entry revealing prophase-specific changes to the phosphoproteome

PLK1 phosphorylation of ZW10 guides accurate chromosome segregation in mitosis

Phosphorylation of PP1 Regulator Sds22 by PLK1 Ensures Accurate Chromosome Segregation.

The Balance of Polo-like Kinase 1 in Tumorigenesis

PLK1-Mediated Phosphorylation Cascade Activates the Mis18 Complex to Ensure Centromere Inheritance

Advances in Research of Ser/Thr Kinase Polo-Like Kinase 1

PKIS: computational identification of protein kinases for experimentally discovered protein phosphorylation sites

PLK1 Phosphorylates Mitotic Centromere-associated Kinesin and Promotes Its Depolymerase Activity

Polo-Like Kinase-1 is a Pivotal Regulator of Microtubule Assembly During Mouse Oocyte Meiotic Maturation, Fertilization, and Early Embryonic Mitosis1